GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (FRA:3JR) » Definitions » ROC (Joel Greenblatt) %

Sopharma AD-Sofia (FRA:3JR) ROC (Joel Greenblatt) % : 15.18% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sopharma AD-Sofia ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sopharma AD-Sofia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 15.18%.

The historical rank and industry rank for Sopharma AD-Sofia's ROC (Joel Greenblatt) % or its related term are showing as below:

FRA:3JR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 6.32   Med: 11.3   Max: 20.39
Current: 18.87

During the past 13 years, Sopharma AD-Sofia's highest ROC (Joel Greenblatt) % was 20.39%. The lowest was 6.32%. And the median was 11.30%.

FRA:3JR's ROC (Joel Greenblatt) % is ranked worse than
53.61% of 97 companies
in the Medical Distribution industry
Industry Median: 21.95 vs FRA:3JR: 18.87

Sopharma AD-Sofia's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 18.80% per year.


Sopharma AD-Sofia ROC (Joel Greenblatt) % Historical Data

The historical data trend for Sopharma AD-Sofia's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia ROC (Joel Greenblatt) % Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.22 6.32 16.07 14.12 20.56

Sopharma AD-Sofia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.77 24.03 23.28 11.72 15.18

Competitive Comparison of Sopharma AD-Sofia's ROC (Joel Greenblatt) %

For the Medical Distribution subindustry, Sopharma AD-Sofia's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia's ROC (Joel Greenblatt) % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's ROC (Joel Greenblatt) % falls into.



Sopharma AD-Sofia ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(120.941 + 157.133 + 44.312) - (122.222 + 0 + 17.159)
=183.005

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(117.991 + 171.119 + 0.045000000000016) - (184.455 + 0 + 11.789)
=92.911

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Sopharma AD-Sofia for the quarter that ended in Dec. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=48.544/( ( (183.165 + max(183.005, 0)) + (180.343 + max(92.911, 0)) )/ 2 )
=48.544/( ( 366.17 + 273.254 )/ 2 )
=48.544/319.712
=15.18 %

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma AD-Sofia  (FRA:3JR) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Sopharma AD-Sofia ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (FRA:3JR) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (FRA:3JR) Headlines

No Headlines